Search Results 261-270 of 16735 for alt

1. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   ... ALT ≤ 2.5 x ULN ; Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within ...

2. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   SGPT (ALT) ≤ 3 x ULN; Creatinine ≤1.5 x ULN. Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only. Patient ...

3. Testing A Standardized Approach To Surgery And Chemotherapy For Type I Pleuropulmonary Blastoma Or The Addition Of An Anti-cancer Drug, Topotecan, To The Usual Treatment For Types II And III Pleuropulmonary Blastoma - Mayo Clinic

   ... [ALT]) ≤ 135 U/L. Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L. Shortening fraction of ≥ 27% by ...

4. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

   AST or ALT > 2.5 x Upper Limit of Normal at the local institution's laboratory;; History of drug, alcohol, or chemical abuse within 6 months prior to ...

5. Combination Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma - Mayo Clinic

   AST and ALT < 2 times ULN; Shortening fraction ≥ 27% by echocardiogram; Ejection fraction ≥ 47% by radionuclide angiogram; No evidence of dyspnea at rest ...

6. A Study Of The Effect Of Ixazomib On The Reservoir Of T Cells Infected With HIV DNA - Mayo Clinic

   ALT <1.5 x ULN; Creatinine <2.0 x ULN and an estimated creatinine clearance > 60 ml/min. HIV infection with suppressed viral replication on at least 3 active ...

7. Statins and CPAP in Adipose Tissue of OSA - Mayo Clinic

   Elevated ALT (> 3 times upper normal limit). Fasting glucose > 120 mg/dL and/or HbA1c ≥ 6.5%. Females planning to be pregnant in next six months. Known ...

8. A Study To Investigate The Effectiveness And Safety Of Injectafer For The Treatment Of Restless Legs Syndrome - Mayo Clinic

   ... ALT greater than the upper limit of normal); Known positive HIV-1/HIV-2 antibodies (anti-HIV); Received an investigational drug within 30 days before ...

9. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

10. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    Abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; CrCl = creatinine clearance; GFR = glomerular filtration rate; INR ...